Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- The Panic Trade: A 20-Stock Defensive Growth Portfolio
Oct 12, 2008 08:42 PM
- Periodicals Wrap-Up for Wednesday, August 13th
Aug 13, 2008 10:06 AM
- Osiris Therapeutics to Present at the Jefferies Second Annual Healthcare Conference and Invitrogen Partners With International Regulome Consortium to Advance Stem Cell Research for the Development of Life Saving Therapies
Jun 19, 2008 09:29 AM
- Small Diagnostic Firms Under Microscope As Gene Focus Rises
Jun 17, 2008 03:25 PM
- Applied Biosys Holders Get Desired Deal, But Premium Lacking
Jun 12, 2008 06:04 PM
- UPDATE:Applied Biosys Deal Value May Fall With Invitrogen Stock
Jun 12, 2008 03:49 PM
- Value Of Applied Biosys Buyout May Fall With Invitrogen Stock
Jun 12, 2008 01:22 PM
- UPDATE: Invitrogen To Buy Applied Biosystems For $6.7 Billion
Jun 12, 2008 11:39 AM
- Invitrogen-Applied Bio Deal Sees About $60 Million Synergies In '09
Jun 12, 2008 10:21 AM
- Invitrogen To Buy Applied Biosystems For $6.7 Billion
Jun 12, 2008 09:14 AM
- Invitrogen and Applied Biosystems Complete Merger
Nov 21, 2008 03:31 PM
- Invitrogen and Applied Biosystems Announce Preliminary Results of Election Regarding Merger Consideration
Nov 20, 2008 08:31 AM
- Invitrogen Launches In Vivo RNAi Delivery Reagent
Nov 19, 2008 04:05 PM
- Standard & Poor's Announces Changes to U.S. Indices
Nov 17, 2008 06:45 PM
- Invitrogen and Applied Biosystems Announce European Commission Merger Clearance
Nov 11, 2008 12:37 PM
- Invitrogen Launches Microarray to Study Non-Coding RNA
Nov 06, 2008 08:30 AM
- Invitrogen Provides Update on Merger with Applied Biosystems
Nov 04, 2008 04:32 PM
- Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: IVGN, DENN, POT, NOK, CP, MF
Oct 30, 2008 10:20 AM
- Invitrogen Announces Third Quarter 2008 Financial Results
Oct 21, 2008 04:10 PM
- Invitrogen and Applied Biosystems Amend Merger Agreement to Eliminate Tax Opinion Condition; Stockholder Meetings to Be Moved to October 28, 2008
Oct 15, 2008 08:39 AM
- Form 4 BARTHELEMY NICOLAS For: Nov 14 (10K)
Nov 18, 2008 08:03 PM
- Form 4 Brust Bernd For: Nov 14 (10K)
Nov 18, 2008 08:00 PM
- Form 4 BENCHIMOL CLAUDE For: Nov 14 (10K)
Nov 18, 2008 08:00 PM
- Form 4 COTTINGHAM JOHN A For: Nov 14 (10K)
Nov 18, 2008 08:00 PM
- Form 4 Hoffmeister David F For: Nov 14 (10K)
Nov 18, 2008 08:00 PM
- Form 4 Leddy Peter Michael For: Nov 14 (10K)
Nov 18, 2008 08:00 PM
- Form 4 LUCIER GREGORY T For: Nov 14 (10K)
Nov 18, 2008 08:00 PM
- Form 4 INVITROGEN CORP For: Nov 14 Filed by: MATRICARIA RONALD A (10K)
Nov 18, 2008 07:57 PM
- Form 4 INVITROGEN CORP For: Aug 01 Filed by: RICHARD KELLI (10K)
Aug 05, 2008 06:54 PM
- Form 4 INVITROGEN CORP For: Jul 05 Filed by: Leddy Peter Michael (10K)
Jul 08, 2008 06:34 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
IVGN
|
Compare to S&P
|
| YTD |
-52.40 %
|
-12.64 %
|
| 4 Weeks |
-16.49 %
|
-8.48 %
|
| 12 Weeks |
-47.65 %
|
-16.05 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -7.35 %
|
|
EPS Growth in Last Year: 23.53 %
|
|
Sales Growth in Last Quarter: -1.66 %
|
|
Sales Growth in Last Quarter: 14.84 %
|
|
|
